URS 2009 - BRCA2 mutation confers an increased risk of aggressive prostate cancer in Australia and New Zealand - Abstract
PORT DOUGLAS, AUSTRALIA (UroToday.com) - To determine the significance of BRCA2 mutation in men with prostate cancer in families affected by breast cancer vs. non-BRCA2 patients with prostate cancer from such families with a history of breast cancer.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
